Research Article
No access
Published Online: 1 May 2012

Diabetes and Its Chronic Complications in the She Ethnic Minority Group of China

Publication: Diabetes Technology & Therapeutics
Volume 14, Issue Number 5

Abstract

Objective: According to recent reports, the development of type 2 diabetes in China has soared at an alarming rate. However, most of the investigations were based on Han people, who account for the majority of people in China. Little is known about the prevalence of diabetes its chronic complications in the She people, who have their own traditional lifestyle and hereditable background, different from other Asian population. The present study investigated the prevalence of type 2 diabetes and associated risk factors in the adult population of She nationals.
Subjects and Methods: A total of 5,385 participants entered into the analysis eventually, including 2,308 men and 3,077 women. An oral glucose tolerance test was performed in subjects without diagnosed diabetes. Liver function, cardiovascular risk (brachial–ankle pulse wave velocity, estimated glomerular filtration rate, and abnormal Minnesota codes findings), uric acid, and neuropathy were tested to assess the profiles of associated risks.
Results: In general, the self-reported diabetes rate was 9.5%. After age and sex standardization, the prevalence of diabetes was 6.1% (6.7% for men and 5.7% for women) in She Chinese people. In logistic regression models, age, family history of diabetes, alcohol use, total cholesterol, and triglycerides were all significantly associated with the risk of diabetes in this cross-sectional study (all P<0.05). In all, 47.4% had cardiovascular risks, 19.4% had liver dysfunction, and 6.2% had hyperuricemia. For women, compared with the first quartile, log-transformed homeostasis model assessment for insulin resistance of the fourth quartile was significantly higher (P<0.05), and log-transformed homeostasis model assessment for β cells was also higher in the second, third, and fourth quartiles (all P<0.05). The prevalences of polyneuropathy in impaired fasting glucose (IFG), impaired glucose tolerance (IGT), IFG/IGT, and diabetes mellitus (DM) were 16.1%, 13.1%, 18.6%, and 28.4% separately, which was higher than that in normal glucose tolerance. The prevalences of polyneuropathy in IFG/IGT and DM were higher than that in IGT.
Conclusions: The present study revealed that a total of 6.1% She people suffered from type 2 diabetes, which was lower than the average level of China, but the standardized prevalence of prediabetes was higher, 20.6%. Early peripheral neuropathy screening should be performed in the prediabetes population. The Toronto Clinical Neuropathy Scoring System is convenient to assess diabetic polyneuropathy in clinical practice and should be tested regularly for people in prediabetes. Liver dysfunction, headache, and insomnia, appearing before type 2 diabetes, should be assessed regularly to avoid deterioration.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Wild SSicree RRoglic GKing HGreen A. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030Diabetes Care2004271047-1053. 1. Wild S, Sicree R, Roglic G, King H, Green A: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–1053.
2.
Yang WYLu JMWeng JPJia WPJi LNXiao JZShan ZYLiu JTian HMJi QHZhu DLGe JPLin LXChen LGuo XHZhao ZGLi QZhou ZGShan GLHe J. Prevalence of diabetes among men and women in ChinaN Engl J Med20103621090-101. 2. Yang WY, Lu JM, Weng JP, Jia WP, Ji LN, Xiao JZ, Shan ZY, Liu J, Tian HM, Ji QH, Zhu DL, Ge JP, Lin LX, Chen L, Guo XH, Zhao ZG, Li Q, Zhou ZG, Shan GL, He J: Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090–101.
3.
Blackburn HKeys ASimonson ERautaharju PPunsar S. The electrocardiogram in population studies. A classification systemCirculation1960211160-1175. 3. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S: The electrocardiogram in population studies. A classification system. Circulation 1960;21:1160–1175.
4.
Relationship of blood pressure, serum cholesterol, smoking habits, relative weight, ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. The Pooling Project Research GroupJ Chronic Dis197831201-306. 4. Relationship of blood pressure, serum cholesterol, smoking habits, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. The Pooling Project Research Group. J Chronic Dis 1978;31:201–306.
5.
Matthews DRHosker JPRudenski ASNaylor BATreacher DFTurner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia198528412-419. 5. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
6.
Alberti KGZimmet PZ. Definition, diagnosis, classification of diabetes mellitus, its complications. Part 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultationDiabet Med199815539-553. 6. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998;15:539–553.
7.
Cockcroft DWGault HM. Prediction of creatinine clearance from serum creatinineNephron19761631-41. 7. Cockcroft DW, Gault HM: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41.
8.
DuBois DDuBois EF. A formula to estimate the approximate surface area if height and weight be knownArch Intern Med191617863-871. 8. DuBois D, DuBois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863–871.
9.
Levey ASCoresh JBalk EKausz ATLevin ASteffes MWHogg RJPerrone RDLau JEknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratificationAnn Intern Med2003139137-147. 9. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med 2003;139:137–147.
10.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAm J Kidney Dis2002392 Suppl 1S1-S266. 10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1–S266.
11.
Tsuchiya MSuzuki EEgawa KNishio YMaegawa HInoue SMitsunami KMorikawa SInubushi TKashiwagi A. Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patientsDiabetes Care2004272409-2415. 11. Tsuchiya M, Suzuki E, Egawa K, Nishio Y, Maegawa H, Inoue S, Mitsunami K, Morikawa S, Inubushi T, Kashiwagi A: Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patients. Diabetes Care 2004; 27:2409–2415.
12.
Lin LXChen GZou XZhao JZhu FTu MXu SLin WYang SZhang YLin MChen NHuang HLiang JLi LYao J. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast ChinaObes Rev200910420-430. 12. Lin LX, Chen G, Zou X, Zhao J, Zhu F, Tu M, Xu S, Lin W, Yang S, Zhang Y, Lin M, Chen N, Huang H, Liang J, Li L, Yao J: Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China. Obes Rev 2009;10:420–430.
13.
Nakanishi NOkamoto MYoshida HMatsuo YSuzuki KTatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workersEur J Epidemiol200318523-530. 13. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K: Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18:523–530.
14.
Dehghan Avan Hoek MSijbrands EJHofman AWitteman JC. High serum uric acid as a novel risk factor for type 2 diabetesDiabetes Care200831361-362. 14. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC: High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361–362.
15.
Chien KLChen MFHsu HCChang WTSu TCLee YTHu FB. Plasma uric acid and the risk of type 2 diabetes in a Chinese communityClin Chem200854310-316. 15. Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, Hu FB: Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 2008;54:310–316.
16.
Taniguchi YHayashi TTsumura KEndo GFujii SOkada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: Osaka Health SurveyJ Hypertens2001191209-1215. 16. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K: Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: Osaka Health Survey. J Hypertens 2001;19:1209–1215.
17.
Dehghan Avan Hoek MSijbrands EJGHofman AWitteman JCM. High serum uric acid as a novel risk factor for type 2 diabetesDiabetes Care200831361-362. 17. Dehghan A, van Hoek M, Sijbrands EJG, Hofman A, Witteman JCM: High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361–362.
18.
De Fronzo RA. Lilly Lecture 1987: The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDMDiabetes198837667-687. 18. De Fronzo RA: Lilly Lecture 1987: The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667–687.
19.
Erbey JRSilberman CLydick E. Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetesAm J Med2000109588-590. 19. Erbey JR, Silberman C, Lydick E: Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. Am J Med 2000;109:588–590.
20.
Lee DHJacobs DR JrGross MKiefe CIRoseman JLewis CESteffes M. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) StudyClin Chem2003491358-1366. 20. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M: Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358–1366.
21.
Salmela PISotaniemi EANiemi MMaentausta O. Liver function tests in diabetic patientsDiabetes Care19847248-254. 21. Salmela PI, Sotaniemi EA, Niemi M, Maentausta O: Liver function tests in diabetic patients. Diabetes Care 1984;7:248–254.
22.
Lee DHHa MHKim JHChristiani DCGross MDSteffes MBlomhoff RJacobs DR Jr. Gamma-glutamyltransferase and diabetes—a 4 year follow-up studyDiabetologia200346359-364. 22. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs DR Jr: Gamma-glutamyltransferase and diabetes—a 4 year follow-up study. Diabetologia 2003;46:359–364.
23.
Sillanpää MAro H. Headache in teenagers: comorbidity and prognosisFunct Neurol200015Suppl 3116-121. 23. Sillanpää M, Aro H: Headache in teenagers: comorbidity and prognosis. Funct Neurol 2000;15(Suppl 3):116–121.
24.
Cook NRBenseñor IMLotufo PALee IMSkerrett PJChown MJAjani UAManson JEBuring JE. Migraine and coronary heart disease in women and menHeadache200242715-727. 24. Cook NR, Benseñor IM, Lotufo PA, Lee IM, Skerrett PJ, Chown MJ, Ajani UA, Manson JE, Buring JE: Migraine and coronary heart disease in women and men. Headache 2002;42:715–727.
25.
Kurth TGaziano JMCook NRLogroscino GDiener HCBuring JE. Migraine, risk of cardiovascular disease in womenJAMA2006296283-291Erratum in: JAMA 2006;296:654, 2006;296:1 p following 291. 25. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE: Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283–291. Erratum in: JAMA 2006;296:654, 2006;296:1 p following 291.
26.
Knutson KLSpiegel KPenev PVan Cauter E. The metabolic consequences of sleep deprivationSleep Med Rev200711163-178. 26. Knutson KL, Spiegel K, Penev P, Van Cauter E: The metabolic consequences of sleep deprivation. Sleep Med Rev 2007;11:163–178.
27.
Ford ESZhao GLi C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidenceJ Am Coll Cardiol2010551310-1317. 27. Ford ES, Zhao G, Li C: Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 2010;55:1310–1317.
28.
Pecoraro REReiber GEBurgess EM. Pathways to diabetic limb amputation: basis for preventionDiabetes Care199013513-521. 28. Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990;13:513–521.
29.
Singleton JRSmith AGBromberg MB. Painful sensory polyneuropathy associated with impaired glucose toleranceMuscle Nerve2001241225-1228. 29. Singleton JR, Smith AG, Bromberg MB: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001;24;1225–1228.
30.
Tesfaye SBoultion AJDyck PJFreeman RHorowitz MKempler PLauria GMalik RASpallone VVinik ABernardi LValensi P. Toronto Diabetic Neuropathy Expert Group: Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, treatmentsDiabetes Care2010332285-2293Erratum in: Diabetes Care 2010;33:2725. 30. Tesfaye S, Boultion AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group: Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285–2293. Erratum in: Diabetes Care 2010;33:2725.
31.
Abbott CACarrington ALAshe HBath SEvery LCGriffiths JHann AWHussein AJackson NJohnson KERyder CHTorkington RVan Ross ERWhalley AMWiddows PWilliamson SBoulton AJ. North-West Diabetes Foot Care Study: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohortDiabet Med200219377-384. 31. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJ; North-West Diabetes Foot Care Study: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002;19:377–384.

Information & Authors

Information

Published In

cover image Diabetes Technology & Therapeutics
Diabetes Technology & Therapeutics
Volume 14Issue Number 5May 2012
Pages: 430 - 439
PubMed: 22304539

History

Published in print: May 2012
Published online: 1 May 2012
Published ahead of print: 3 February 2012

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Yinghua Lin
*
Department of Endocrinology, Ningde Municipal Hospital, Fujian Medical University, Ningde, China.
Yuan Xu*
Department of Endocrinology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Gang Chen*
Department of Endocrinology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Xiaolan Lai*
Department of Endocrinology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Baoying Huang
Department of Endocrinology, Ningde Municipal Hospital, Fujian Medical University, Ningde, China.
Zichun Chen
Department of Endocrinology, Ningde Municipal Hospital, Fujian Medical University, Ningde, China.
Longteng Yao
Department of Endocrinology, Ningde Municipal Hospital, Fujian Medical University, Ningde, China.
Shaoheng Zhu
Department of Endocrinology, Ningde Municipal Hospital, Fujian Medical University, Ningde, China.
Jin Yao
Department of Endocrinology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Junping Wen
Department of Endocrinology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Huibin Huang
Department of Endocrinology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Caijing Lin
Department of Emergency, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.

Notes

Address correspondence to:Gang Chen, M.D., Ph.D.Department of EndocrinologyFujian Provincial HospitalFujian Medical UniversityBox 4-70492 Huqian RoadFuzhou, Fujian,China 350003
E-mail: [email protected]
orCaijing Lin, M.D.Department of EmergencyFujian Provincial HospitalFujian Medical UniversityFuzhou 350001,China
E-mail: [email protected]

Author Disclosure Statement

The authors have nothing to declare.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top